Experience

Davis Polk advised the representative of the underwriters in connection with an SEC-registered offering by Webster Financial Corporation of $300 million aggregate principal amount of its 4…

Davis Polk advised the representatives of the underwriters on the SEC-registered initial public offering by UP Fintech Holding Limited (Tiger Trade) of 13,000,000 American Depositary Shares…

Davis Polk advised the representatives of the several underwriters in connection with Synchrony Financial’s SEC-registered offering of $1.25 billion aggregate principal amount of senior…

Davis Polk is advising Morgan Stanley on its $900 million acquisition of Solium Capital Inc. The transaction is expected to close in the second quarter of 2019, subject to shareholder and…

Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the approximately $225 million initial public offering by Orchard Therapeutics…

Davis Polk advised the representatives of the underwriters in connection with the $50 million initial public offering of 6,250,000 ordinary shares of Gamida Cell Ltd. The ordinary…

Davis Polk advised the initial purchasers in connection with a $500 million offering of 7.000% senior notes due 2026 by JBS Investments II GmbH and guaranteed by JBS S.A., which were…

Davis Polk is advising Mitsubishi UFJ Lease & Finance Co., Ltd. (“MUL”) on its acquisition of ENGS Holdings Inc. from a group of shareholders represented by Aquiline Capital Partners…

Davis Polk advised the joint book-runners and representatives of the underwriters on an SEC-registered offering by Fluor Corporation of $600 million aggregate principal amount of its 4…

Davis Polk advised Auris Medical Holding AG on a public offering of common shares and warrants. The common shares are listed on the NASDAQ Global Market under the symbol “EARS.” Auris…